Wednesday, March 05, 2025 | 09:48 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Laurus gets USFDA nod for drug that treats malaria, auto-immune disease

Medicine is a therapeutic equivalent of Plaquenil tablets of Concordia Pharma of US

Labs, Science, Laurus
Premium

Labs, Science, Laurus

BS Reporter Hyderabad
Hyderabad-based Laurus Labs Limited said announced on Monday that it has received a final approval from the US Food and Drug Administration(US FDA) for Hydroxychloroquine tablets 200 mg, which is used for treatment of certain types of Malaria.

This medication is also used, usually with other medications, to treat certain auto-immune diseases (lupus, rheumatoid arthritis) when other medications have not worked or cannot be used. The drug is a therapeutic equivalent of Plaquenil tablets of Concordia Pharmaceuticals, Inc.

In another development, the company also received a tentative approval for an abbreviated new drug application (ANDA) for Abacavir, Dolutegravir and Lamivudine

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in